Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Ecf506 Compound
2. Tert-butyl (4-(4-amino-1-(2-(4-(dimethylamino)piperidin-1-yl)ethyl)-1h-pyrazolo(3,4-d)pyrimidin-3-yl)-2-methoxyphenyl)carbamate
1. 1914078-41-3
2. Ecf-506
3. Tert-butyl (4-(4-amino-1-(2-(4-(dimethylamino)piperidin-1-yl)ethyl)-1h-pyrazolo[3,4-d]pyrimidin-3-yl)-2-methoxyphenyl)carbamate
4. Chembl3824089
5. Derivative 11a [pmid: 27115835]
6. Tert-butyl N-[4-[4-amino-1-[2-[4-(dimethylamino)piperidin-1-yl]ethyl]pyrazolo[3,4-d]pyrimidin-3-yl]-2-methoxyphenyl]carbamate
7. Derivative 11a (pmid: 27115835)
8. Tert-butyl N-[4-(4-amino-1-{2-[4-(dimethylamino)piperidin-1-yl]ethyl}-1h-pyrazolo[3,4-d]pyrimidin-3-yl)-2-methoxyphenyl]carbamate
9. Derivative 11a
10. Tert-butyl N-(4-(4-amino-1-(2-(4-(dimethylamino)piperidin-1-yl)ethyl)-1h-pyrazolo(3,4-d)pyrimidin-3-yl)-2-methoxyphenyl)carbamate
11. Tert-butyl N-[4-(4-amino-1-{2-[4-(dimethylamino)piperidin-1-yl]ethyl}pyrazolo[3,4-d]pyrimidin-3-yl)-2-methoxyphenyl]carbamate
12. Gtpl9186
13. Nxp900
14. Schembl18258375
15. Ex-a3152
16. Bdbm50184767
17. Nsc854154
18. Akos040759429
19. Nsc-854154
20. Ac-36398
21. Be166437
22. Da-52795
23. Ms-29482
24. Hy-112096
25. Cs-0043341
26. D87145
27. Q27077149
28. Ucw
| Molecular Weight | 510.6 g/mol |
|---|---|
| Molecular Formula | C26H38N8O3 |
| XLogP3 | 2.6 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 9 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 124 |
| Heavy Atom Count | 37 |
| Formal Charge | 0 |
| Complexity | 742 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
62
PharmaCompass offers a list of NXP900 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right NXP900 manufacturer or NXP900 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred NXP900 manufacturer or NXP900 supplier.
PharmaCompass also assists you with knowing the NXP900 API Price utilized in the formulation of products. NXP900 API Price is not always fixed or binding as the NXP900 Price is obtained through a variety of data sources. The NXP900 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A NXP900 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of NXP900, including repackagers and relabelers. The FDA regulates NXP900 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. NXP900 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A NXP900 supplier is an individual or a company that provides NXP900 active pharmaceutical ingredient (API) or NXP900 finished formulations upon request. The NXP900 suppliers may include NXP900 API manufacturers, exporters, distributors and traders.
NXP900 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of NXP900 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right NXP900 GMP manufacturer or NXP900 GMP API supplier for your needs.
A NXP900 CoA (Certificate of Analysis) is a formal document that attests to NXP900's compliance with NXP900 specifications and serves as a tool for batch-level quality control.
NXP900 CoA mostly includes findings from lab analyses of a specific batch. For each NXP900 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
NXP900 may be tested according to a variety of international standards, such as European Pharmacopoeia (NXP900 EP), NXP900 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (NXP900 USP).
